Tag: Chemotherapy
Olanzapine, Prochlorperazine Both Alleviate Refractory Chemo-Related Nausea
Findings seen for patients with breast cancer starting a high/moderate emetogenic chemotherapy regimen
2023 Cisplatin Shortage Tied to Use of Alternatives for Head, Neck Cancer
Alternative treatments came at significantly higher costs for both payers, patients
Pembrolizumab + Chemo Beneficial for Early-Stage Triple-Negative Breast Cancer
Overall survival higher in group receiving pembrolizumab plus chemo versus chemotherapy alone
Neoadjuvant Chemo Boosts Structure Preservation Rates in Nasal, Sinus Cancer
Improvement seen in overall structure preservation rate, orbit preservation rate, and skull base preservation rate
Tusamitamab Ravtansine Does Not Extend Survival With Nonsquamous NSCLC
Findings seen in patients previously treated with platinum-based chemotherapy and immunotherapy whose tumors highly expressed CEACAM5
Long-Course Chemoradiotherapy Preferred TNT Regimen for Rectal Cancer
LCCRT results in higher two-year organ preservation and lower two-year local regrowth compared with short-course radiotherapy
Omitting 5-FU Bolus Does Not Reduce Survival in Advanced Cancer
However, omission does result in reductions in neutropenia, thrombocytopenia, and use of granulocyte colony-stimulating factor
Suicide Risk Higher for Cancer Patients Not Proceeding With Recommended Surgery
No associations seen for radiotherapy, chemotherapy and excess suicide
Pharmacogenomic Score Can Personalize Treatment of Leukemia in Children
Patients in low ACS10 score group have significantly improved survival with clofarabine+cytarabine treatment
Blinatumomab + Chemo Ups Survival in B-Cell Precursor Acute Lymphoblastic Leukemia
Improved overall survival and three-year relapse-free survival seen with blinatumomab plus chemo for adult patients
